In contrast to very immature dendritic cells (DC), mature DC are largely re
sistant to death by CD95 (CD95/APO-1) ligation. Investigation of other pote
ntial death-inducing ligands showed that mature DC were instead highly susc
eptible to apoptosis induced by cross-linking of MHC class II. Thus, increa
sing DC maturity correlates with increased resistance to CD95 killing, but
an increased susceptibility to class II-mediated killing. Anti-I-A/I-E mono
clonal antibodies (mAb) induced rapid (<2 h) apoptotic cell death in mature
epidermal, spleen and bone marrow-derived DC, as determined by annexin/pro
pidium iodide staining, morphological changes, decreased diploidy and loss
in mitochondrial membrane potential. Although full class II-mediated killin
g required DC cytoskeletal motion, divalent cations and phosphatase activit
y, neither caspase activation, respiration, RNA or protein synthesis, NO pr
oduction, nor CD95:CD95L interactions were required. Strikingly, DC pretrea
ted by CD40 mAb crosslinking, but not by lipopolysaccharide or TNF-alpha, w
ere completely resistant to class II-mediated killing. CD40-mediated protec
tion was reduced in the presence of the SB202190 inhibitor of the mitogen-a
ctivated protein kinase p38 pathway, but appeared to be independent of p42/
44 extracellular signal-related kinase or NF-KB activation. Our findings sh
ow that in addition to its role as an activator of antigen-presenting cell
function, CD40 provides an important counter-signal against class II-induce
d apoptosis. Thus, these data point to an important role of the T cell in r
egulating DC survival.